Cardiac safety and efficacy for patients with early-stage breast cancer treated with pegylated liposomal doxorubicin (PLD) or doxorubicin.

医学 心脏毒性 阿霉素 乳腺癌 临床终点 内科学 射血分数 癌症 心力衰竭 环磷酰胺 外科 化疗 随机对照试验 肿瘤科
作者
Lichen Tang,Min He,Jiong Wu,Zhonghua Wang,Guang-Yu Liu,Ke‐Da Yu,Cuizhi Geng,Zhimin Fan,Rui Ling,Guangdong Qiao,Li Cai,Ting Luo,Feng Jin,Haibo Wang,Anqin Zhang,Hongwei Zhang,Xiaohua Zeng,Xiaojia Wang,Ming Jiang,Zhimin Shao
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:41 (16_suppl): 550-550
标识
DOI:10.1200/jco.2023.41.16_suppl.550
摘要

550 Background: Anthracyclines play an important role in the treatment of breast cancer (BC) while cardiotoxicity, a serious side effect, limits the clinical application. Pegylated liposomal doxorubicin (PLD) is a new dosage form of doxorubicin encapsulated in liposomes, which can reduce the plasma free level of doxorubicin and drug to normal tissue delivery, thereby reducing cardiotoxicity. The aim of this study was to evaluate the cardiac safety and efficacy of PLD compared with doxorubicin as adjuvant therapy in breast cancer patients. Methods: This is an open-label, randomized trial involving patients with operable breast cancer who were at high risk of recurrence after radical sugery (NCT03949634). Patients were randomized (1:1) to receive adjuvant PLD or doxorubicin (A) and cyclophosphamide followed by taxanes ± trastuzumab. The primary endpoint was cardiotoxicity, which was defined as congestive heart failure (CHF) with clinical symptoms, or no symptoms but with an abnormal left ventricular ejection fraction (LVEF). Secondary endpoints included 5-year disease-free survival (DFS) rate, 5-year overall survival (OS) rate and safety. Results: Between November 2017 and September 2019, 247 patients were randomized and received study treatment (PLD arm, 131; A arm, 116). The median age was 49 years (range, 26-67) in PLD arm and 48 years (range, 25-70) in A arm. The pathological stages were 18.3% stage I, 58.0% stage II, and 22.1% stage III in PLD arm, while those of A arm were 20.7% stage I, 59.5% stage II, and 19.8% stage III. The median follow-up time was 43.0 months. The incidence of abnormal LVEF was 0 in the PLD arm and 1.7% the A arm (P = 0.220). The incidence of CHF was 0 in the PLD arm and 0.9% the A arm (P = 0.470). Survival data analysis is immature. The exploratory analysis of cardiac-related biomarkers showed that the incidence of high-sensitivity cardiac troponin-T (hs-cTnT) was lower in PLD arm than in A arm (3.8% vs. 30.2%, P < 0.001). Grade 3/4 adverse events (AEs) occurred in 42.7% patients in PLD arm and in 61.2% patients in A arm. The most common grade 3/4 AEs in PLD arm and A arm included neutropenia (34.4% vs. 55.2%), leukopenia (30.5% vs. 39.7%), and hand-foot syndrome (4.6% vs. 0.0%). Conclusions: Hs-cTnT elevation may have a role in the AE prediction of antharcycline. PLD usage may present lower incidence of cardiotoxicity than doxorubicin in the adjuvant treatment of patients with early-stage breast cancer. Clinical trial information: NCT03949634 .
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大力初珍完成签到 ,获得积分10
刚刚
1秒前
SHAO应助马瑞轩采纳,获得10
1秒前
1秒前
邦邦应助Astralis采纳,获得10
1秒前
2秒前
2秒前
2秒前
Ryan发布了新的文献求助10
3秒前
3秒前
甜甜玫瑰发布了新的文献求助10
3秒前
3秒前
汶溢完成签到,获得积分10
3秒前
收拾收拾应助Fayss采纳,获得10
4秒前
4秒前
5秒前
李大柱完成签到,获得积分10
5秒前
5秒前
JinyuGuo完成签到,获得积分10
5秒前
云舒应助标致的绿柏采纳,获得20
6秒前
yzkkzy完成签到,获得积分10
6秒前
xugiri发布了新的文献求助10
7秒前
7秒前
自然的李完成签到,获得积分10
7秒前
Akim应助过时的明辉采纳,获得10
7秒前
yangyangyang发布了新的文献求助30
8秒前
香蕉觅云应助wy1693207859采纳,获得10
8秒前
Yahui发布了新的文献求助10
8秒前
搞怪的之云完成签到,获得积分20
8秒前
X10230发布了新的文献求助10
9秒前
9秒前
天天快乐应助云瑾采纳,获得10
9秒前
10秒前
10秒前
10秒前
11秒前
小楼发布了新的文献求助200
11秒前
12秒前
12秒前
冰coke完成签到,获得积分10
12秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 310
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3979289
求助须知:如何正确求助?哪些是违规求助? 3523220
关于积分的说明 11216715
捐赠科研通 3260668
什么是DOI,文献DOI怎么找? 1800176
邀请新用户注册赠送积分活动 878854
科研通“疑难数据库(出版商)”最低求助积分说明 807111